Skip to content

Efficacy of Conservative Treatment of Functional Defecatory Disorders in Females With Pelvic Organ Prolapse

Evaluation of Complex (Physical Therapy and Diet) Treatment of Functional Defecatory Disorders in Females With Pelvic Organ Prolapse

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04547816
Enrollment
100
Registered
2020-09-14
Start date
2020-07-01
Completion date
2026-05-31
Last updated
2025-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Floor Prolapse, Functional Constipation, Rectocele

Keywords

pelvic floor prolapse, conservative treatment, functional disorders of defecation, rectocele, diet modification, biofeedback therapy, tibial neuromodulation

Brief summary

This study is planned to evaluate the efficacy of complex conservative treatment (including tibial neuromodulation, biofeedback therapy, special pelvic floor training and diet modification) in women with pelvic organ prolapse

Detailed description

Pelvic organ prolapse is a condition with impaired anatomic structure, which may result in defecatory disorders and usually considered as an indication for surgery. However, operation is not always possible. Existing data suggest that functional component may also be possible, despite on the anatomic impairment. The aim of the study is to evaluate the effect of complex conservative treatment of functional defecatory disorders in patients with mild to moderate grade of pelvic organ prolapse

Interventions

Biofeedback therapy is a procedure when the patient is taught to make proper squeezing by adequate increase of intra-abdominal and rectal pressures and relaxation of the muscles of the pelvic floor. This procedure is widely described and is to be performed with the use of devices registered for this purpose Urostim and WPM Solar, MMS, the Netherlands

PROCEDURETibial neuromodulation

TNM is a standard procedure that is previously described as an effective method to treat functional insufficiency of the anal sphincter. It acts on the lumbosacral nerve plexus with an electric current through the posterior tibial nerve of one of the patient's limbs. For the study purpose a registered device for electric therapy (BioBravo, MTR Plus Vertriebs GmbH, Germany) is to be used.

PFMT is a complex of 5 exercises aimed to make functional training of pelvic floor muscles. This complex does not require additional equipment. It may be performed at home. The patients will be trained to perform this complex of exercises by a healthcare provider. The complex of physical therapy consists of a single basic exercise for training coordinated muscle tension of abdominal wall and relaxation of the pelvic floor muscles, and 4 exercises to increase the contractility of pelvic floor muscles without additional involvement of the muscles of the abdominal wall. This allows to coordinate and consciously control the contraction and relaxation of the pelvic diaphragm. Initial course of training is 10 working days. Than patients continue the intervention for 6 months at home with online monitoring of the correctness and regularity of training.

BEHAVIORALDiet modification

Diet modification play an important role in the regulation of colonic transit and defecation. Dietary factors may act through faecal bulk by additional stimulation of mechanoreceptors of the rectum. At the same time, adequate intake of vitamins (for example, B12) may improve electric conductivity of nerves and thus impact the tone of pelvic floor muscles. Among other factors known to affect functional state of pelvic floor muscles and colonic transit are dietary fibers, adequate intake of water, regular meal intake. For the study purposes, it is planned to provide standard recommendation based on the national recommended daily allowances according to patients' sex, age and physical activity level.

Sponsors

State Scientific Centre of Coloproctology, Russian Federation
CollaboratorOTHER_GOV
Ministry of Health, Russian Federation
CollaboratorOTHER_GOV
Ministry of Science and Higher Education, Russian Federation
CollaboratorUNKNOWN
Federal State Budgetary Scientific Institution Federal Research Centre of Nutrition, Biotechnology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

After randomization eligible subjects are to receive one of the treatment option described in the Model Description according to the order placed in a closed envelope which is to be opened by person who perform biofeedback (BFT) and tibial neuromodulation (TNM). The investigator responsible for the study conduction, clinical assessment and high-resolution anorectal manometry measurements is not supposed to get the information about the number of procedures (BFT+TNM; or BFT+TNM + pelvic floor muscles training (PFMT); or BFT+TNM + PFMT + diet modification (DM)) that a certain subject receives

Intervention model description

Random assignment to one of the groups depending on the treatment options: 1. biofeedback and tibial neuromodulation 2. biofeedback and tibial neuromodulation + pelvic floor muscles training 3. biofeedback and tibial neuromodulation + pelvic floor muscles training + diet modification

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Willingness to participate (signed informed consent form) * Females with rectocele I-II grade or rectocele I-II grade and internal rectal invagination and functional defecatory disorders (per Rome IV guidelines) confirmed on the basis of complex examination including high-resolution anorectal manometry

Exclusion criteria

* rectocele III grade; * internal genitals prolapse; * history of abdominal or pelvic surgery that may impact bowel motility (excluding non-complicated appendectomy or laparoscopic cholecystectomy); * gynecological surgery that may influence sensory or reservoir function of rectum; * history of major cardiovascular events, or presence of current conditions that in case of participation of the patient in the study may put her at risk of exacerbation or complication; * start of any new concomitant medication with mechanisms of action that influence rectal motility, sensory function, muscle tone and/or contractility * inability to understand and/or follow the instructions to perform all the procedures required per protocol * general condition of the patient that make her ineligible by the discretion of the investigator

Design outcomes

Primary

MeasureTime frameDescription
Mean stool frequencyA weekclinical outcome
Mean stool form valueA weekclinical outcome, assessed with the use of the Bristol stool scale (BSS)
Mean defecation with difficult bowel emptyinga weekpatient-reported outcome, clinical
Change of KESS scale pointsat the end-point, 6 months after enrolmentA specialized validated questionnaire will be used before treatment and at the end of the study. Change is to be assessed as percentage decline from baseline values.
Change in Scale of bowel evacuatory function assessmentat the end-point, 6 months after enrolmentA specialized validated questionnaire will be used before treatment and at the end of the study. Change is to be assessed as percentage decline from baseline v
Average anal resting pressureat the end-point, 6 months after enrolmentValues obtained during HR anorectal manometry
Maximum absolute anal squeeze pressureat the end-point, 6 months after enrolmentValues obtained during HR anorectal manometry
Average absolute anal squeeze pressureat the end-point, 6 months after enrolmentValues obtained during HR anorectal manometry
Average incremental anal squeeze pressureat the end-point, 6 months after enrolmentat the end-point, 6 months after enrolmentValues obtained during HR anorectal manometry
Residual push pressureat the end-point, 6 months after enrolmentValues obtained during HR anorectal manometry
Push relaxation percentageat the end-point, 6 months after enrolmentValues obtained during HR anorectal manometry

Countries

Russia

Contacts

Primary ContactSergey Morozov, MD, PhD
morosoffsv@mail.ru+79104681801
Backup ContactOksana Fomenko, MD, PhD
oksana671@yandex.ru+79164817323

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026